English

AMEXDRUG CORP

EDGAR

Quarterly report (10-Q) · filed 2013-08-14

69 filing records in this dataset, filed from 1995-05-15 to 2013-08-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.1 million USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 3100218 USD Source

Operating cash flow

94.4 thousand USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -151617 USD Source
Operating Cash Flow: -246046 USD Source

Cash and cash equivalents: 142 thousand USD 2011-09-30 Source
Exact value

141542 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

12.4 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Revenue: 11487177 USD · 2010-01-01 – 2010-12-31 Source
Revenue: 8622365 USD · 2010-01-01 – 2010-09-30 Source
Revenue: 2840717 USD · 2011-01-01 – 2011-03-31 Source
Revenue: 3621079 USD · 2011-04-01 – 2011-06-30 Source
Revenue: 3100218 USD · 2011-07-01 – 2011-09-30 Source

Net income

304 thousand USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Net income: 189062 USD · 2010-01-01 – 2010-12-31 Source
Net income: 203061 USD · 2010-01-01 – 2010-09-30 Source
Net income: 164111 USD · 2011-01-01 – 2011-03-31 Source
Net income: 71549 USD · 2011-04-01 – 2011-06-30 Source
Net income: 82521 USD · 2011-07-01 – 2011-09-30 Source

Operating cash flow

-102 thousand USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Operating cash flow: 226784 USD · 2010-01-01 – 2010-12-31 Source
Operating cash flow: 177140 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: -120088 USD · 2011-01-01 – 2011-03-31 Source
Operating cash flow: -246046 USD · 2011-01-01 – 2011-06-30 Source
Operating cash flow: -120088 USD · 2011-01-01 – 2011-03-31 Source
Operating cash flow: -151617 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: -246046 USD · 2011-01-01 – 2011-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-08-14.

Financial data available through: 2010-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2010-12-31
Operating income: 5 of 11 periods available· newest 2007-12-31
Net income: 11 of 11 periods available· newest 2010-12-31
Operating cash flow: 11 of 11 periods available· newest 2010-12-31
Capital expenditure: 2 of 11 periods available· newest 2007-12-31
Total assets: 10 of 11 periods available· newest 2010-12-31
liabilities: No compatible figures in this window
Current assets: 11 of 11 periods available· newest 2010-12-31
Current liabilities: 11 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+17.6%

Prior period

USD 9.77 million

2009-01-01 – 2009-12-31
Current period

USD 11.49 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

11487177 − 9766972 = 1720205 USD

9766972 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
11487177 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · AMEXDRUG CORP · 2010-12-31 AMEXDRUG CORP (edgar:45621) Year-over-year change in Revenue: 1720205 USD Concept: fundies:Revenue Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 11487177 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-11-000623.txt#1810 Input fundies:Revenue: 9766972 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-11-000623.txt#1810
The citation records this snapshot. The page link may show a newer release later.
Net income
+930.5%

Prior period

USD 18,346

2009-01-01 – 2009-12-31
Current period

USD 189,062

2010-01-01 – 2010-12-31

Exact inputs and evidence

189062 − 18346 = 170716 USD

18346 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
189062 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · AMEXDRUG CORP · 2010-12-31 AMEXDRUG CORP (edgar:45621) Year-over-year change in Net income: 170716 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 189062 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-11-000623.txt#1873 Input fundies:NetIncome: 18346 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-11-000623.txt#1873
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 289,530

Prior period

−USD 62,746

2009-01-01 – 2009-12-31
Current period

USD 226,784

2010-01-01 – 2010-12-31

Exact inputs and evidence

226784 − -62746 = 289530 USD

-62746 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
226784 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · AMEXDRUG CORP · 2010-12-31 AMEXDRUG CORP (edgar:45621) Year-over-year change in Operating cash flow: 289530 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 226784 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-11-000623.txt#1894 Input fundies:OperatingCashFlow: -62746 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-11-000623.txt#1894
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 11.49 million 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income USD 189,062 1.6% of revenue

Cash

Operating cash flow USD 226,784 2% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Not shown: operating income or net income is not reported.
2002 Not shown: operating income or net income is not reported.
2003 100%
2004 Operating loss: operating costs were 102% of revenue.
2005 Net income was higher than operating income, so the split is not drawn.
2006 Net income was higher than operating income, so the split is not drawn.
2007 100%
2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2001-01-01 – 2001-12-31	21254081	Unavailable	Unavailable	Unavailable	-92078	Unavailable	Source 2001-01-01 – 2001-12-31: 21254081 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -92078 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 142401 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	22249952	Unavailable	Unavailable	Unavailable	-18040	Unavailable	Source 2002-01-01 – 2002-12-31: 22249952 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -18040 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -199861 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	11705672	11678819 Derived	26853	1832 Derived	25021	Unavailable	Source 2003-01-01 – 2003-12-31: 11705672 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 26853 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 25021 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -354878 USD Inspect Operating Cash Flow Open source
2004 2004-01-01 – 2004-12-31	6530485	6685240 Derived	-154755	-165205 Derived	10450	Unavailable	Source 2004-01-01 – 2004-12-31: 6530485 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -154755 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: 10450 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 49377 USD Inspect Operating Cash Flow Open source
2005 2005-01-01 – 2005-12-31	4950960	4938253 Derived	12707	-1456 Derived	14163	Unavailable	Source 2005-01-01 – 2005-12-31: 4950960 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 12707 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 14163 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 165229 USD Inspect Operating Cash Flow Open source
2006 2006-01-01 – 2006-12-31	4649835	4630051 Derived	19784	-1383 Derived	21167	-99688 Derived	Source 2006-01-01 – 2006-12-31: 4649835 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 19784 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 21167 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -99688 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 0 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	6139635	6123463 Derived	16172	4736 Derived	11436	104866 Derived	Source 2007-01-01 – 2007-12-31: 6139635 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 16172 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 11436 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 120910 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 16044 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	5693502	Unavailable	Unavailable	Unavailable	12332	Unavailable	Source 2008-01-01 – 2008-12-31: 5693502 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 12332 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -193706 USD Inspect Operating Cash Flow Open source
2009 2009-01-01 – 2009-12-31	9766972	Unavailable	Unavailable	Unavailable	18346	Unavailable	Source 2009-01-01 – 2009-12-31: 9766972 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 18346 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -62746 USD Inspect Operating Cash Flow Open source
2010 2010-01-01 – 2010-12-31	11487177	Unavailable	Unavailable	Unavailable	189062	Unavailable	Source 2010-01-01 – 2010-12-31: 11487177 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 189062 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: 226784 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 11.5M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Revenue	21254081	Revenue: 21254081 Open source
20022002-12-31	Revenue	22249952	Revenue: 22249952 Open source
20032003-12-31	Revenue	11705672	Revenue: 11705672 Open source
20042004-12-31	Revenue	6530485	Revenue: 6530485 Open source
20052005-12-31	Revenue	4950960	Revenue: 4950960 Open source
20062006-12-31	Revenue	4649835	Revenue: 4649835 Open source
20072007-12-31	Revenue	6139635	Revenue: 6139635 Open source
20082008-12-31	Revenue	5693502	Revenue: 5693502 Open source
20092009-12-31	Revenue	9766972	Revenue: 9766972 Open source
20102010-12-31	Revenue	11487177	Revenue: 11487177 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

17.6% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Year over year	155.5%	Revenue: 21254081 Open source Revenue: 8317033 Open source
20022002-12-31	Year over year	4.7%	Revenue: 22249952 Open source Revenue: 21254081 Open source
20032003-12-31	Year over year	-47.4%	Revenue: 11705672 Open source Revenue: 22249952 Open source
20042004-12-31	Year over year	-44.2%	Revenue: 6530485 Open source Revenue: 11705672 Open source
20052005-12-31	Year over year	-24.2%	Revenue: 4950960 Open source Revenue: 6530485 Open source
20062006-12-31	Year over year	-6.1%	Revenue: 4649835 Open source Revenue: 4950960 Open source
20072007-12-31	Year over year	32%	Revenue: 6139635 Open source Revenue: 4649835 Open source
20082008-12-31	Year over year	-7.3%	Revenue: 5693502 Open source Revenue: 6139635 Open source
20092009-12-31	Year over year	71.5%	Revenue: 9766972 Open source Revenue: 5693502 Open source
20102010-12-31	Year over year	17.6%	Revenue: 11487177 Open source Revenue: 9766972 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 0.3% 2007

Net margin 1.6% 2010

Free cash flow margin 1.7% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Operating margin	Not reported	Revenue: 21254081 Open source
2002-12-31	Operating margin	Not reported	Revenue: 22249952 Open source
20032003-12-31	Operating margin	0.2%	Operating Income: 26853 Open source Revenue: 11705672 Open source
20042004-12-31	Operating margin	-2.4%	Operating Income: -154755 Open source Revenue: 6530485 Open source
20052005-12-31	Operating margin	0.3%	Operating Income: 12707 Open source Revenue: 4950960 Open source
20062006-12-31	Operating margin	0.4%	Operating Income: 19784 Open source Revenue: 4649835 Open source
20072007-12-31	Operating margin	0.3%	Operating Income: 16172 Open source Revenue: 6139635 Open source
2008-12-31	Operating margin	Not reported	Revenue: 5693502 Open source
2009-12-31	Operating margin	Not reported	Revenue: 9766972 Open source
2010-12-31	Operating margin	Not reported	Revenue: 11487177 Open source
20012001-12-31	Net margin	-0.4%	Net Income: -92078 Open source Revenue: 21254081 Open source
20022002-12-31	Net margin	-0.1%	Net Income: -18040 Open source Revenue: 22249952 Open source
20032003-12-31	Net margin	0.2%	Net Income: 25021 Open source Revenue: 11705672 Open source
20042004-12-31	Net margin	0.2%	Net Income: 10450 Open source Revenue: 6530485 Open source
20052005-12-31	Net margin	0.3%	Net Income: 14163 Open source Revenue: 4950960 Open source
20062006-12-31	Net margin	0.5%	Net Income: 21167 Open source Revenue: 4649835 Open source
20072007-12-31	Net margin	0.2%	Net Income: 11436 Open source Revenue: 6139635 Open source
20082008-12-31	Net margin	0.2%	Net Income: 12332 Open source Revenue: 5693502 Open source
20092009-12-31	Net margin	0.2%	Net Income: 18346 Open source Revenue: 9766972 Open source
20102010-12-31	Net margin	1.6%	Net Income: 189062 Open source Revenue: 11487177 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 21254081 Open source Operating Cash Flow: 142401 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 22249952 Open source Operating Cash Flow: -199861 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 11705672 Open source Operating Cash Flow: -354878 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 6530485 Open source Operating Cash Flow: 49377 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 4950960 Open source Operating Cash Flow: 165229 Open source
20062006-12-31	Free cash flow margin	-2.1%	Revenue: 4649835 Open source Operating Cash Flow: -99688 Open source Capital Expenditure: 0 Open source
20072007-12-31	Free cash flow margin	1.7%	Revenue: 6139635 Open source Operating Cash Flow: 120910 Open source Capital Expenditure: 16044 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 5693502 Open source Operating Cash Flow: -193706 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 9766972 Open source Operating Cash Flow: -62746 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 11487177 Open source Operating Cash Flow: 226784 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 226.8K 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Operating cash flow	142401	Operating Cash Flow: 142401 Open source
20022002-12-31	Operating cash flow	-199861	Operating Cash Flow: -199861 Open source
20032003-12-31	Operating cash flow	-354878	Operating Cash Flow: -354878 Open source
20042004-12-31	Operating cash flow	49377	Operating Cash Flow: 49377 Open source
20052005-12-31	Operating cash flow	165229	Operating Cash Flow: 165229 Open source
20062006-12-31	Operating cash flow	-99688	Operating Cash Flow: -99688 Open source
20072007-12-31	Operating cash flow	120910	Operating Cash Flow: 120910 Open source
20082008-12-31	Operating cash flow	-193706	Operating Cash Flow: -193706 Open source
20092009-12-31	Operating cash flow	-62746	Operating Cash Flow: -62746 Open source
20102010-12-31	Operating cash flow	226784	Operating Cash Flow: 226784 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 104.9K 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: 142401 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: -199861 Open source
20032003-12-31	Free cash flow	Unavailable	Operating Cash Flow: -354878 Open source
20042004-12-31	Free cash flow	Unavailable	Operating Cash Flow: 49377 Open source
20052005-12-31	Free cash flow	Unavailable	Operating Cash Flow: 165229 Open source
20062006-12-31	Free cash flow	-99688	Operating Cash Flow: -99688 Open source Capital Expenditure: 0 Open source
20072007-12-31	Free cash flow	104866	Operating Cash Flow: 120910 Open source Capital Expenditure: 16044 Open source
20082008-12-31	Free cash flow	Unavailable	Operating Cash Flow: -193706 Open source
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: -62746 Open source
20102010-12-31	Free cash flow	Unavailable	Operating Cash Flow: 226784 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Liabilities / assets	Not reported	Total Assets: 1825468 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 1490603 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 611935 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 420103 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 461704 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 494300 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 694997 Open source
2008-12-31	Liabilities / assets	Not reported	Total Assets: 709403 Open source
2009-12-31	Liabilities / assets	Not reported	Total Assets: 798415 Open source
2010-12-31	Liabilities / assets	Not reported	Total Assets: 1341537 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.19× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Current assets / current liabilities	0.93×	Current Assets: 1718444 Open source Current Liabilities: 1839091 Open source
20022002-12-31	Current assets / current liabilities	0.91×	Current Assets: 1417095 Open source Current Liabilities: 1556401 Open source
20032003-12-31	Current assets / current liabilities	0.82×	Current Assets: 544357 Open source Current Liabilities: 666657 Open source
20042004-12-31	Current assets / current liabilities	0.79×	Current Assets: 375496 Open source Current Liabilities: 472960 Open source
20052005-12-31	Current assets / current liabilities	0.88×	Current Assets: 362777 Open source Current Liabilities: 409949 Open source
20062006-12-31	Current assets / current liabilities	0.91×	Current Assets: 421146 Open source Current Liabilities: 463528 Open source
20072007-12-31	Current assets / current liabilities	0.98×	Current Assets: 637936 Open source Current Liabilities: 652789 Open source
20082008-12-31	Current assets / current liabilities	1.01×	Current Assets: 662899 Open source Current Liabilities: 654863 Open source
20092009-12-31	Current assets / current liabilities	1.02×	Current Assets: 749775 Open source Current Liabilities: 734813 Open source
20102010-12-31	Current assets / current liabilities	1.19×	Current Assets: 1294658 Open source Current Liabilities: 1091030 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 92,078 Exact value Exact value: -92078 USD 2001-01-01 – 2001-12-31: -92078 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMEXDRUG CORP · 2001-12-31 AMEXDRUG CORP (edgar:45621) Net Income: -92078 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -92078 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-03-000164.txt#1431 The citation records this snapshot. The page link may show a newer release later.	USD 142,401 Exact value Exact value: 142401 USD 2001-01-01 – 2001-12-31: 142401 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMEXDRUG CORP · 2001-12-31 AMEXDRUG CORP (edgar:45621) Operating Cash Flow: 142401 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 142401 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-03-000164.txt#1444 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 18,040 Exact value Exact value: -18040 USD 2002-01-01 – 2002-12-31: -18040 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMEXDRUG CORP · 2002-12-31 AMEXDRUG CORP (edgar:45621) Net Income: -18040 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18040 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-04-000154.txt#1507 The citation records this snapshot. The page link may show a newer release later.	−USD 199,861 Exact value Exact value: -199861 USD 2002-01-01 – 2002-12-31: -199861 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMEXDRUG CORP · 2002-12-31 AMEXDRUG CORP (edgar:45621) Operating Cash Flow: -199861 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -199861 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-04-000154.txt#1521 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	USD 25,021 Exact value Exact value: 25021 USD 2003-01-01 – 2003-12-31: 25021 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMEXDRUG CORP · 2003-12-31 AMEXDRUG CORP (edgar:45621) Net Income: 25021 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 25021 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-05-000148.txt#1580 The citation records this snapshot. The page link may show a newer release later.	−USD 354,878 Exact value Exact value: -354878 USD 2003-01-01 – 2003-12-31: -354878 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMEXDRUG CORP · 2003-12-31 AMEXDRUG CORP (edgar:45621) Operating Cash Flow: -354878 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -354878 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-05-000148.txt#1597 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	USD 10,450 Exact value Exact value: 10450 USD 2004-01-01 – 2004-12-31: 10450 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMEXDRUG CORP · 2004-12-31 AMEXDRUG CORP (edgar:45621) Net Income: 10450 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: 10450 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-06-000321.txt#1515 The citation records this snapshot. The page link may show a newer release later.	USD 49,377 Exact value Exact value: 49377 USD 2004-01-01 – 2004-12-31: 49377 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMEXDRUG CORP · 2004-12-31 AMEXDRUG CORP (edgar:45621) Operating Cash Flow: 49377 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 49377 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-06-000321.txt#1533 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	USD 14,163 Exact value Exact value: 14163 USD 2005-01-01 – 2005-12-31: 14163 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMEXDRUG CORP · 2005-12-31 AMEXDRUG CORP (edgar:45621) Net Income: 14163 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 14163 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-07-000554.txt#1522 The citation records this snapshot. The page link may show a newer release later.	USD 165,229 Exact value Exact value: 165229 USD 2005-01-01 – 2005-12-31: 165229 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMEXDRUG CORP · 2005-12-31 AMEXDRUG CORP (edgar:45621) Operating Cash Flow: 165229 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 165229 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-07-000554.txt#1540 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	USD 21,167 Exact value Exact value: 21167 USD 2006-01-01 – 2006-12-31: 21167 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMEXDRUG CORP · 2006-12-31 AMEXDRUG CORP (edgar:45621) Net Income: 21167 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 21167 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-08-001501.txt#1488 The citation records this snapshot. The page link may show a newer release later.	−USD 99,688 Exact value Exact value: -99688 USD 2006-01-01 – 2006-12-31: -99688 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMEXDRUG CORP · 2006-12-31 AMEXDRUG CORP (edgar:45621) Operating Cash Flow: -99688 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -99688 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-08-001501.txt#1508 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2006-01-01 – 2006-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMEXDRUG CORP · 2006-12-31 AMEXDRUG CORP (edgar:45621) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-08-001501.txt#1512 The citation records this snapshot. The page link may show a newer release later.	−USD 99,688 Calculation and evidence -99688 − 0 USD Exact free cash flow: -99688 USD 2006-01-01 – 2006-12-31: -99688 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMEXDRUG CORP · 2006-12-31 AMEXDRUG CORP (edgar:45621) Free cash flow: -99688 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -99688 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-08-001501.txt#1508 Input fundies:CapitalExpenditure: 0 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-08-001501.txt#1512 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	USD 11,436 Exact value Exact value: 11436 USD 2007-01-01 – 2007-12-31: 11436 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMEXDRUG CORP · 2007-12-31 AMEXDRUG CORP (edgar:45621) Net Income: 11436 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 11436 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-09-000359.txt#1882 The citation records this snapshot. The page link may show a newer release later.	USD 120,910 Exact value Exact value: 120910 USD 2007-01-01 – 2007-12-31: 120910 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMEXDRUG CORP · 2007-12-31 AMEXDRUG CORP (edgar:45621) Operating Cash Flow: 120910 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 120910 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-09-000359.txt#1901 The citation records this snapshot. The page link may show a newer release later.	USD 16,044 Exact value Exact value: 16044 USD 2007-01-01 – 2007-12-31: 16044 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · AMEXDRUG CORP · 2007-12-31 AMEXDRUG CORP (edgar:45621) Capital Expenditure: 16044 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16044 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-08-001501.txt#1512 The citation records this snapshot. The page link may show a newer release later.	USD 104,866 Calculation and evidence 120910 − 16044 USD Exact free cash flow: 104866 USD 2007-01-01 – 2007-12-31: 120910 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 16044 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · AMEXDRUG CORP · 2007-12-31 AMEXDRUG CORP (edgar:45621) Free cash flow: 104866 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 120910 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-09-000359.txt#1901 Input fundies:CapitalExpenditure: 16044 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-08-001501.txt#1512 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	USD 12,332 Exact value Exact value: 12332 USD 2008-01-01 – 2008-12-31: 12332 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMEXDRUG CORP · 2008-12-31 AMEXDRUG CORP (edgar:45621) Net Income: 12332 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 12332 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-10-000376.txt#1914 The citation records this snapshot. The page link may show a newer release later.	−USD 193,706 Exact value Exact value: -193706 USD 2008-01-01 – 2008-12-31: -193706 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMEXDRUG CORP · 2008-12-31 AMEXDRUG CORP (edgar:45621) Operating Cash Flow: -193706 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -193706 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-10-000376.txt#1932 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	USD 18,346 Exact value Exact value: 18346 USD 2009-01-01 – 2009-12-31: 18346 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMEXDRUG CORP · 2009-12-31 AMEXDRUG CORP (edgar:45621) Net Income: 18346 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 18346 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-11-000623.txt#1873 The citation records this snapshot. The page link may show a newer release later.	−USD 62,746 Exact value Exact value: -62746 USD 2009-01-01 – 2009-12-31: -62746 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMEXDRUG CORP · 2009-12-31 AMEXDRUG CORP (edgar:45621) Operating Cash Flow: -62746 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -62746 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-11-000623.txt#1894 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	USD 189,062 Exact value Exact value: 189062 USD 2010-01-01 – 2010-12-31: 189062 USD Inspect Net Income Open source Share or cite Citation for Net Income · AMEXDRUG CORP · 2010-12-31 AMEXDRUG CORP (edgar:45621) Net Income: 189062 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 189062 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-11-000623.txt#1873 The citation records this snapshot. The page link may show a newer release later.	USD 226,784 Exact value Exact value: 226784 USD 2010-01-01 – 2010-12-31: 226784 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · AMEXDRUG CORP · 2010-12-31 AMEXDRUG CORP (edgar:45621) Operating Cash Flow: 226784 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:22:51Z Snapshot: a3c5420bbaf616d3d1506af0c2d11fe9c67895193365b1c020675373de79fc70 Dimensions: Consolidated View: https://fundies.io/companies/edgar/45621/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 226784 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/45621/0001096906-11-000623.txt#1894 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

69 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000045621, 45621, edgar:45621

Also known as HARLYN PRODUCTS INC

AMEXDRUG CORP

Latest quarter

Revenue

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation